DM

Devaprasad Mamillapalli

Active Director Director DIN 09217801
DIN 09217801 First appointment Jul 2021 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Devaprasad Mamillapalli

Data last updated:

Devaprasad Mamillapalli is a Director at Right Remedies Association (since 2021). The company operates in Non-Profit Organizations.

DIN 09217801
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 28 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Right Remedies Association U85300TG2021NPL153575
Director28 Jul 20212021Active

Board colleagues of Devaprasad Mamillapalli

Directorship timeline

Open interactive timeline →
Right Remedies Association
Premium access

Shareholding and investment profile for Devaprasad Mamillapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devaprasad Mamillapalli

Devaprasad Mamillapalli currently holds 1 directorship: Right Remedies Association (Director, since 28 Jul 2021).

Devaprasad Mamillapalli was first appointed on 28 Jul 2021 as Director at Right Remedies Association.

The current boards of Devaprasad Mamillapalli's companies include Nageswararao Valiveti (Right Remedies Association), Venkata Surendra Kumar Koya (Right Remedies Association), Vijender Reddy Kalluri (Right Remedies Association).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available